← Leaderboards
Michael L. Radomsky
Epicyte Pharmaceutical, Inc.
$299,999
Attributed
$299,999
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,999 · 1
By mechanism
R43$299,999 · 1
Top collaborators
No co-investigators on record.
Most similar at Epicyte Pharmaceutical, Inc.
Same institution · by research overlap
- Larry Zeitlin$59,655,519
Others in their field
Top investigators on “Alphaherpesvirinae”
- Gregory Allan Smith · Albert Einstein College Of Medicine$4,780,726
- Bernard Roizman · University Of Alabama At Birmingham$4,673,409
- Donald M Coen · University Of Pennsylvania$4,391,905
- Barry T. Rouse · University Of Tennessee Knoxville$2,726,346
- David J. Fink · University Of Pittsburgh At Pittsburgh$2,481,223
- Saul J Silverstein · Columbia University Health Sciences$2,460,770
Research focus
AlphaherpesvirinaeAntiviral AgentsAntiviral AntibodyBiotechnologyDisease /Disorder ModelDrug Design /Synthesis /ProductionGenital HerpesHybrid AntibodyLaboratory MouseMonoclonal AntibodyTopical Drug Application